| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals, Inc. (RYTM) has 15 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 111.9K | $11.35M | - | |
| Other | 25.5K | $2.58M | - | |
| CEO | 14.1K | $1.43M | - | |
| Other | 8.4K | $849.1K | - | |
| Dir | 7.0K | $713.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2017 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 355,000 | $17.00 | $6,035,000.00 | +61.0% | |
| Oct 10, 2017 | Foley Todd82 | Director, 10% Owner | Buy | 100,000 | $17.00 | $1,700,000.00 | +3.9% | |
| Oct 10, 2017 | Kerins Patrick J70 | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | Mpm Bioventures V, L.P. | 10% Owner | Buy | 100,000 | $17.00 | $1,700,000.00 | +3.9% | |
| Oct 10, 2017 | Mott David M88 | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | Baskett Forest53 | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | Barris Peter J | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | Barrett M James | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | Viswanathan Ravi | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 10, 2017 | New Enterprise Associates 13 LP68 | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% |